New hope for tiny babies: experimental drug targets deadly gut disease
Disease control
Recruiting now
This study tests an experimental drug called ST266 in infants with necrotizing enterocolitis (NEC), a severe gut infection. The goal is to see if the drug is safe and helps babies recover faster. About 36 infants will receive one of two doses of ST266 by IV.
Phase: PHASE1, PHASE2 • Sponsor: Noveome Biotherapeutics, formerly Stemnion • Aim: Disease control
Last updated May 14, 2026 12:03 UTC